FindTrial
Sign In

Radiofrequency ablation versus repeated resection for hepatitis B recurrent hepatocellular carcinoma

Radiofrequency ablation versus repeated resection for hepatitis B recurrent hepatocellular carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019348
Enrollment
Unknown
Registered
2018-11-07
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

RFA group and Repeated Resection group:N/A
Repeated Resection group:N/A

Sponsors

Shandong Provincial Hospital Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients older than 18 years; 2) Recurrent HCC after initial surgical resection; 3) The initial surgical resection of HCC was based on the criteria of treatment guidelines of AASLD; 4) Patients with Child-Pugh class A or B; 5) The treatment of recurrent HCC was repeated resection or RFA.

Exclusion criteria

Exclusion criteria: 1) Vascular invasion and extrahepatic metastasis at recurrence; 2) Combined with other important organs dysfunction; 3) Absence of 6 month follow-up after treatment.

Design outcomes

Primary

MeasureTime frame
treatment response;Complication;Outcome;—

Countries

China

Contacts

Public ContactQiang Zhu

Shandong Provincial Hospital Affiliated to Shandong University

zhuqiang@medmail.com.cn+86 0531-68777012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026